Adial Pharmaceuticals (ADIL) Long-Term Investments (2023 - 2026)

Adial Pharmaceuticals has reported Long-Term Investments for 4 years, with the latest figure at $421730.0 in Q1 2026.

• Quarterly Long-Term Investments fell 48.49% year-over-year to $421730.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $421730.0 (down 48.49% YoY) and the FY2025 annual result came in at $489700.0, down 50.12% from the prior year.
• Long-Term Investments declined to $421730.0 in Q1 2026 per ADIL's latest filing, from $489700.0 in the prior quarter.
• Over five years, Long-Term Investments peaked at $1.7 million in Q2 2023 and troughed at $421730.0 in Q1 2026.
• A 4-year average of $1.1 million and a median of $1.0 million in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments sank 35.08% in 2024, then sank 50.12% in 2025.
• Over 4 years, Long-Term Investments stood at $1.5 million in 2023, then plunged by 36.0% to $981830.0 in 2024, then tumbled by 50.12% to $489700.0 in 2025, then retreated by 13.88% to $421730.0 in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $421730.0, $489700.0, and $643090.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.